SCHEMBL4885580

SCHEMBL4885580

CC1(S)CCC(NN)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26487771 0.79 EPHX2 (0.37)
Hydrochloric Acid SCHEMBL15540415 0.77 EPHX2 (0.36)
SCHEMBL20940060 0.75 ESR2 (0.36)
SCHEMBL18973735 0.71
SCHEMBL4849204 0.70
SCHEMBL19116204 0.70
SCHEMBL1717640 0.69 EPHX2 (0.36)
Hydrochloric Acid SCHEMBL2074512 0.68 LMNA (0.31)
SCHEMBL19455992 0.68
SCHEMBL15522382 0.67 ADH1B (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378438-B2 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2008-05-27 US disclosed
US-20050228184-A1 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2005-10-13 US disclosed